文献速递肺结节与肺癌慢阻肺肺栓塞与肺血管病

联合肺部与心脏CT生物标志物用于肺癌筛查中的疾病特异性风险建模

Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening.
PubMed 文献 · Eur Respir J · 2021-09-02

该研究基于国家肺癌筛查试验(n=15 000)和意大利多中心肺癌检测数据(n=2287),构建并验证结合CT定量指标与患者特征的肺癌、心血管病死亡和慢阻肺死亡风险模型。结果显示,CT指标对结节为基础的肺癌风险预测有小幅但可重复的改善,而患者自报特征在已有CT信息时可能不增加预测价值。

要点

  • 年龄、平均肺密度、肺气肿评分、支气管壁厚度和主动脉钙化体积对三个最终模型均有贡献。
  • 结节特征对肺癌预测关键,但不贡献心血管病和慢阻肺死亡预测。
  • CT模型联合患者特征对慢阻肺死亡预测提升最大,但因事件频率极低未进行外部验证。

核心结论

  • 心血管病和慢阻肺的CT指标可小幅但可重复地改善基于结节的肺癌风险预测。
  • 当CT信息可用时,患者自报特征可能不增加预测价值。

研究设计与样本

  • 使用简约Cox回归在National Lung Screening Trial样本(n=15 000)中推导模型。
  • 使用Multicentric Italian Lung Detection数据(n=2287)进行外部验证。
  • 分别构建仅患者特征、仅CT信息和所有变量的调查模型、CT模型和最终模型。

主要发现

  • 年龄、平均肺密度、肺气肿评分、支气管壁厚度和主动脉钙化体积是所有最终模型的贡献变量。
  • 推导队列中肺癌发病CT模型5年AUC为82.5%(95%CI 80.9-84.0%),低于最终模型84.0%(82.6-85.5%)。
  • 验证队列中肺癌发病CT模型AUC为80.1%(74.2-86.0%),最终模型为79.9%(73.9-85.8%)。
  • 推导队列中心血管病死亡最终模型AUC为79.1%(77.0-81.2%),优于调查模型74.9%(72.7-77.1%)和CT模型76.3%(74.1-78.5%)。
  • 慢阻肺死亡最终模型AUC为92.3%(90.1-94.5%),高于调查模型87.5%(84.3-90.6%)和CT模型87.9%(84.8-91.0%)。

临床怎么用

  • 在肺癌筛查中可考虑联合CT定量指标评估心血管病和慢阻肺风险。
  • 结节特征对肺癌风险预测仍为核心,CT指标提供额外小幅改善。
  • 患者自报特征在已有CT信息时可能无需额外采集以提升预测。

局限性

  • 慢阻肺死亡模型因事件频率极低未进行外部验证。
  • 患者特征在验证队列中未显示对肺癌和心血管病死亡模型的附加预测价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Combined assessment of cardiovascular disease (CVD), COPD and lung cancer may improve the effectiveness of lung cancer screening in smokers. The aims were to derive and assess risk models for predicting lung cancer incidence, CVD mortality and COPD mortality by combining quantitative computed tomography (CT) measures from each disease, and to quantify the added predictive benefit of self-reported patient characteristics given the availability of a CT scan. METHODS: A survey model (patient characteristics only), CT model (CT information only) and final model (all variables) were derived for each outcome using parsimonious Cox regression on a sample from the National Lung Screening Trial (n=15 000). Validation was performed using Multicentric Italian Lung Detection data (n=2287). Time-dependent measures of model discrimination and calibration are reported. RESULTS: Age, mean lung density, emphysema score, bronchial wall thickness and aorta calcium volume are variables that contributed to all final models. Nodule features were crucial for lung cancer incidence predictions but did not contribute to CVD and COPD mortality prediction. In the derivation cohort, the lung cancer incidence CT model had a 5-year area under the receiver operating characteristic curve of 82.5% (95% CI 80.9-84.0%), significantly inferior to that of the final model (84.0%, 82.6-85.5%). However, the addition of patient characteristics did not improve the lung cancer incidence model performance in the validation cohort (CT model 80.1%, 74.2-86.0%; final model 79.9%, 73.9-85.8%). Similarly, the final CVD mortality model outperformed the other two models in the derivation cohort (survey model 74.9%, 72.7-77.1%; CT model 76.3%, 74.1-78.5%; final model 79.1%, 77.0-81.2%), but not the validation cohort (survey model 74.8%, 62.2-87.5%; CT model 72.1%, 61.1-83.2%; final model 72.2%, 60.4-84.0%). Combining patient characteristics and CT measures provided the largest increase in accuracy for the COPD mortality final model (92.3%, 90.1-94.5%) compared to either other model individually (survey model 87.5%, 84.3-90.6%; CT model 87.9%, 84.8-91.0%), but no external validation was performed due to a very low event frequency. CONCLUSIONS: CT measures of CVD and COPD provides small but reproducible improvements to nodule-based lung cancer risk prediction accuracy from 3 years onwards. Self-reported patient characteristics may not be of added predictive value when CT information is available.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Schreuder A, Jacobs C, Lessmann N, et al. Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. Eur Respir J. 2021. PMID: 33574075. doi:10.1183/13993003.03386-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。